Promising findings for early investigations into CBD and autism

enfleur-blog-autism-cbd-cannabis.jpg

According to the CDC, autism spectrum disorder (ASD) has been identified in one out of every 59 children in the United States. Though the severity of ASD can range from mild to severe, affecting social, emotional, and communication skills, there have been promising results in treating ASD with CBD-rich cannabis. In light of this, ENFLEUR is happy to share a retrospective study published late last year in the Journal of Autism and Developmental Disorders that found that, of the 60 children assessed for tolerability and efficacy of CBD-rich cannabis, 61% saw behavioral outbreaks much to very much improved. Another study published by Scientific Reports in early 2019 found that 83.8% of patients assessed 6 months into CBD-rich cannabis therapy (30% CBD and 1.5% THC) were found to have a moderate to significant improvement, with only 8.6% having no change in their condition. Both studies agree that CBD-rich cannabis is a feasible treatment for ASD because it is well-tolerated and can be quite effective. These are promising preliminary findings for individuals living with ASD, as well as for their families and caregivers. For this reason, as well as CBD’s demonstrated ability to mitigate anxiety (one of the most common psychiatric disorders affecting those with autism) it is worth considering whether integrating a high quality CBD supplement into a wellness routine is right for your family.

Why does this matter? CBD has been shown to reduce the symptoms of autism spectrum disorder.